(Q28296394)

6 July 2017

title

Nomifensine in Parkinson's disease (English)

1 reference

6 July 2017

1 reference

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1977.TB05751.X

25 March 2023

3

Marsden CD

1 reference

6 July 2017

P. Bedard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A334223

25 March 2023

J. D. Parkes

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A334223

25 March 2023

C. D. Marsden

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A334223

25 March 2023

language of work or name

English

0 references

publication date

1 January 1977

1 reference

full work available at URL

6 July 2017

https://europepmc.org/articles/PMC1429119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A334223

https://europepmc.org/articles/PMC1429119?pdf=render

25 March 2023

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A334223

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2125.1977.tb05751.x

25 March 2023

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1111/J.1365-2125.1977.TB05751.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1977.tb05751.x/fullpdf

25 March 2023

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1111/J.1365-2125.1977.TB05751.X

British Journal of Clinical Pharmacology

25 March 2023

published in

1 reference

6 July 2017

volume

4Suppl 2

1 reference

6 July 2017

issue

S2

1 reference

28 June 2019

page(s)

187S-190S

1 reference

Psychiatric symptoms during l-dopa therapy for Parkinson's disease and their relationship to physical disability

6 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429119

8-Amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline, a new antidepressant

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429119

Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429119

Amphetamines in the treatment of Parkinson's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429119

Methylphenidate-like effects of the new antidepressant drug nomifensine (HOE 984).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429119

The effects of blocking catecholamine uptake on amphetamine-induced circling behaviour in mice with unilateral destruction of striatal dopaminergic nerve terminals

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429119

Effect of nomifensine (HOE 984), a new antidepressant, on uptake of noradrenaline and serotonin and on release of noradrenaline in rat brain synaptosomes.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429119

Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429119

Effect of nomifensine on motor activity, dopamine turnover rate and cyclic 3',5;-adenosine monophosphate concentrations of rat striatum.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429119

A study of the role of catecholamines in the response to various central stimulants.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429119

Nomifensine in parkinsonism.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429119

Nomifensine in parkinsonism

28 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1977.TB05751.X

Nomifensine: A potent dopaminergic agonist of antiparkinson potential

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/334223

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

1 reference

6 July 2017

1 reference

6 July 2017

1 reference